Where movement analysis can help

Longitudinal gait phenotyping can distinguish recovery of pace from restoration of interlimb coordination and everyday participation. Analyse speed, spatial progression and temporal asymmetry against pain, loading restrictions, assistive-device transitions and rehabilitation exposure. A change in the composition of sampled walking bouts can otherwise resemble physiological recovery.

Clinical or analytical response. Define an expected trajectory and an escalation criterion that accounts for measurement error and clinical stage. Persistent deterioration or discordance between capacity and participation can prioritise reassessment; examination and diagnostic work-up establish whether pain, weakness, complications or behavioural constraints explain the signal.

Falls emerge from interactions between intrinsic vulnerability, task demands and exposure. Gait variability, turning and support strategy may characterise relevant impairments, but predictive performance depends on cohort spectrum, event ascertainment and prediction horizon. Higher activity can increase exposure while representing better function.

Clinical or analytical response. Embed monitoring within a multifactorial pathway and evaluate calibration, sensitivity, positive predictive value and alerts per patient-time. A service should demonstrate that its response to identified risk changes outcomes, not merely that a score discriminates previous fallers.

Time-resolved gait measures can characterise motor-state fluctuations when acquisition is aligned with medication timing, symptoms and activity context. Distinguish bradykinetic pace changes, turning performance and episodic freezing; a daily mean can obscure opposing or short-lived responses.

Clinical or analytical response. Use repeated within-person observations to test a clinically defined motor-state hypothesis. Control or stratify for task composition and sensor location; retain clinician review because an observed temporal association does not identify the appropriate medication adjustment.

Gait speed integrates several physiological systems and provides a useful functional phenotype in ageing cohorts. Repeated assessment adds trajectory information, while free-living bout distributions describe how capacity is expressed in the person’s environment. Concordant decline across domains strengthens the rationale for broader assessment.

Clinical or analytical response. Interpret prognostic associations at the population level and assess individual change against repeatability, intercurrent illness and measurement conditions. A gait decline can motivate evaluation of functional reserve and reversible contributors without assigning a single cause from the movement signature.

A digital mobility endpoint requires a defined construct, estimand and context of use. Prespecify acquisition, valid observation periods, bout eligibility, aggregation, missing-data handling and analysis version. Measurement burden and selective adherence can alter both the observed population and the endpoint distribution.

Clinical or analytical response. Separate exploratory feature discovery from confirmatory inference. Establish analytical validity, responsiveness and interpretation of change before assigning decision weight to treatment effects; account for multiplicity and repeated observations in the statistical analysis plan.

Cognitive-motor interference offers a mechanistic probe of locomotor automaticity and executive allocation. Dual-task interpretation requires joint analysis of gait and secondary-task performance: slowing may represent a deliberate prioritisation strategy, while preserved speed can coexist with greater variability or reduced cognitive accuracy.

Clinical or analytical response. Specify task difficulty, prioritisation instructions and baseline cognitive performance. Distinguish cross-sectional association from longitudinal prediction, and evaluate whether the gait feature adds information beyond age, comorbidity and conventional cognitive assessment.

Sustained walking performance reflects the interaction of cardiopulmonary capacity, peripheral limitation, pacing and symptoms. A timed-distance test and habitual walking volume address different constructs: standardised exercise performance versus activity expressed under daily constraints.

Clinical or analytical response. Interpret distance alongside symptoms, rests and protocol conditions. For remote follow-up, examine whether a reduced activity total reflects lower capacity, altered opportunity or incomplete observation before attributing it to physiological deterioration.

Within-person comparison can quantify changes in temporal organisation, spatial progression and task performance after device fitting. Symmetry alone is an incomplete target: an apparently more symmetric pattern can occur through deterioration of the less affected limb, and a compensatory strategy may preserve function.

Clinical or analytical response. Prespecify acclimatisation, order effects, walking speed and footwear. Combine gait outcomes with comfort, energy-related outcomes where appropriately measured, safety and participation; select laboratory kinetics or EMG when the clinical question concerns loading or activation rather than footfall timing.

Task-specific movement analysis can examine coordination under fatigue, external load and equipment changes. Transfer from comfortable walking to running or occupational tasks requires new consideration of event definitions, sensor attachment, movement amplitude and reference quality.

Clinical or analytical response. Define the biomechanical hypothesis and exposure conditions before selecting features. Distinguish an observed kinematic adaptation from tissue loading or prospective injury risk, each of which requires a different evidence chain.

Affect can modulate locomotor expression through arousal, attentional allocation and motor strategy. Experimental emotion induction and observational symptom studies address different hypotheses; neither supports a universal decoding of psychological state from a movement trace. Physical comorbidity, medication and social opportunity remain major competing explanations.

Clinical or analytical response. Pair repeated movement observations with contemporaneous, validated symptom measures and prespecified within-person analyses. Evaluate incremental validity and out-of-sample performance rather than interpreting a group-average gait difference as a diagnostic signature.